Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) – Extension Phase
Condition(s):Cystic FibrosisLast Updated:July 30, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:July 30, 2020Completed
Condition(s):Pseudomonas Aeruginosa InfectionLast Updated:June 16, 2020Completed
Condition(s):Cystic FibrosisLast Updated:June 4, 2019Completed
Condition(s):BronchiectasisLast Updated:July 10, 2019Completed
Condition(s):NTM Lung Infection Due to MACLast Updated:February 10, 2020Completed
Condition(s):Mycobacterium Infections, NontuberculousLast Updated:May 7, 2020Completed
Condition(s):Mycobacterium Infections, NontuberculousLast Updated:August 21, 2019Completed
Condition(s):Mycobacterium Infections, Nontuberculous; Mycobacteria, AtypicalLast Updated:March 4, 2020Completed
Condition(s):Healthy VolunteersLast Updated:August 21, 2023Completed
Condition(s):Cystic FibrosisLast Updated:July 30, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.